MI

(redirected from myocardial infarction)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

MI

1. ISO 3166-1 alpha-2 code for the Midway Islands before their re-designation as part of the U.S. Minor Outlying Islands. This was the code used in international transactions to and from bank accounts in the territory.

2. ISO 3166-2 geocode for the Midway Islands. This was used as an international standard for shipping to the Midway Islands.

In both cases, the code is obsolete.
Mentioned in ?
References in periodicals archive ?
Copeptin improves early diagnosis of acute myocardial infarction.
Myocardial infarction in young adults: risk factors and natural history.
Oral contraceptives and the risk of myocardial infarction, New England Journal of Medicine, 2001, 345(25): 1787-1793.
Sense of coherence and mental health profile in first myocardial infarction patients.
Myocardial Infarction Phase 1 Clinical Trial Pipeline Insights
Among the many unanswered questions is how nitrous oxide anesthesia would lead to an increased myocardial infarction risk.
Finally, exposure of post-ischemic injured myocardium to mobilized MNCCD34+ and leukocytes is sustained over the susceptible first week at concentrations markedly exceeding natural cell mobilization, as recently shown in the setting of human studies on myocardial infarction (14).
The newly revised definition of myocardial infarction required specific clinical and/or electrocardiographic findings to be coupled with increased blood concentrations of myocardial troponin (released into the circulation after myocardial cell death).
Approximately 6% of patients with myocardial infarction have no evidence of coronary atherosclerosis by angiography or at autopsy.
The study excluded patients who had a history of myocardial infarction or cerebrovascular events prior to their entry into the study.
Noise is suspected of causing a number of adverse physiologic effects, ranging from hearing loss to myocardial infarction.
The Medicines Company (NASDAQ: MDCO) has announced the results from HERO-2, an international trial studying the effects of ANGIOMAX(R) (bivalirudin) as a potential new treatment among patients receiving fibrinolysis for myocardial infarction (heart attack).

Full browser ?